Prognostic Factors for Percutaneous Microwave Coagulation Therapy of Hepatic Metastases
Ping Liang1,
Baowei Dong1,
Xiaoling Yu1,
Yanrong Yang2,
Dejiang Yu1,
Li Su1,
Qiujin Xiao1 and
Lin Sheng1
1 Department of Ultrasound, Chinese PLA General Hospital, 28 Fuxing Rd.,
Beijing, 100853 China. 2 Chinese PLA Medical Library, 5 Fengtai Rd., Beijing, 100039 China.
Fig. 1A.52-year-old man with rectal cancer. Contrast-enhanced
multidetector (MDCT) scan obtained before microwave treatment shows 3.2
x 3.6 cm metastasis with peripheral enhancement (arrow) in
segment VIII of liver.
Fig. 1B.52-year-old man with rectal cancer. Contrast-enhanced MDCT
scan obtained 1 month after microwave ablation shows 5.2 x 6.0 cm zone
of hypoattenuation without enhancement (arrow), suggestive of
complete response.
Fig. 3.Graph shows 5-year cumulative survival rate of 74 patients
with hepatic metastases who were treated with microwave ablation. Data are
stratified according to number of tumors: one nodule (thin solid
line), two nodules (dashed line), three or more nodules
(thick solid line).
Fig. 4.Graph shows 5-year cumulative survival rate of 74 patients
with hepatic metastases who were treated with microwave ablation. Data are
stratified according to diameter of tumor: 3 cm (thin solid
line), > 3 to 5 cm (dashed line), > 5 cm (thick
solid line).
Fig. 5.Graph shows 5-year cumulative survival rate of 74 patients
with hepatic metastases who were treated with microwave ablation. Data are
stratified according to histologic differentiation: well-differentiated tumor
(thin solid line), moderately differentiated tumor (dashed
line), poorly differentiated tumor (thick solid line).
Fig. 6.Graph shows 5-year cumulative survival rate of 74 patients
with hepatic metastases who were treated with microwave ablation divided
between those without intra- or extrahepatic metastases (thin line)
and those with intra- or extrahepatic metastases (thick line).